New blood test could help detect testicular cancer spread
NCT ID NCT06060873
Summary
This study aims to see how well a specific blood marker (called miRNA-371) can predict if testicular cancer is active and has spread to nearby lymph nodes. It involves about 418 patients who have already had their primary tumor removed. The goal is to determine if this blood test can accurately guide whether a patient needs surgery or can continue with monitoring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TESTICULAR GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles County-USC Medical Center
Los Angeles, California, 90033, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.